The scientists from A*STAR’s Institute of Medical Biology (IMB) and Institute of Molecular and Cell Biology (IMCB) developed a novel methodology to probe single cells for various DNA-methylation errors at multiple loci to reveal failed maintenance of epigenetic mark results in chimeric mice, which display unpredictable phenotypes leading to developmental arrest. This methodology allows the use of a special technique utilizing a microfluidic device to safely extract one cell for performing the assay called “pronuclear transfer” to ameliorate reprogramming defects in embryos. This study not only details the epigenetic reprogramming dynamics in early mammalian embryos, but it also suggests diagnostic and potential future therapeutic applications.
Source: Science, 2013 Sept 6
CRISPR is best known for cutting and changing DNA. Now, researchers are using the technology…
Skin aging is often described as a normal part of getting older. With time, the…
Age is usually counted in birthdays, but biology does not always follow the calendar. Two…
For years, scientists have studied why some organisms live longer than others. While genes play…
Skin aging is commonly divided into two categories: intrinsic aging, which reflects the natural decline…
The human gut is one of the body’s fastest-renewing tissues. Every few days, new cells…